01/22/2020 /
A low Apgar score at 5 minutes, neonatal seizures, focal-onset epilepsy, and focal slowing on electroencephalogram (EEG) are risk factor variables that cumulatively form an accurate model for predicting the risk for drug-resistant epilepsy in children with cerebral palsy.
01/22/2020 /
While seizures have been reported in association with synthetic cannabinoids, the clinical features and prognosis have not been studied.
01/22/2020 /
Children with epilepsy who are as active as peers without epilepsy have good objective measures of sleep despite self-reported fatigue and parent-reported sleep problems.
01/21/2020 /
The data argue for early consideration of WES with iterative reanalysis for patients with epilepsy, particularly those with DEE or epilepsy with intellectual disability.
01/21/2020 /
This study estimates the active (9/1000) and lifetime (16/1000) epilepsy with a remarkable burden of the disease in Sub-Saharan Africa.
01/16/2020 /
Participants of LASSE XIII demonstrated an ability to empathize with their patients in retrospect by portraying the inner feelings of division and imprisonment of those having seizures.
01/16/2020 /
This study states that clinicians should be aware of the possible cutaneous adverse drug reactions induced by levetiracetam to avoid the development of a potentially fatal condition.
01/16/2020 /
Recent epilepsy research news includes findings about “silencing” neurons to gain seizures control, enhanced understanding of how epilepsy affects memory, and more.
01/15/2020 /
Researchers have shown therapeutic efficacy of a new experimental drug in mouse models of Alzheimer’s disease and a rare genetic form of epilepsy known as Dravet syndrome.
